Childhood Cancer Survivors Clinical Trial
Official title:
A Phase II Open Label Pilot Study of the Angiotensin-converting Enzyme Inhibitor, Perindopril, in Pediatric Cancer Survivors With Evidence of Early Cardiac Remodelling or Dysfunction.
Verified date | October 2015 |
Source | The Hospital for Sick Children |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Health Canada |
Study type | Interventional |
The purpose of this study is to evaluate the feasibility of conducting a medical intervention trial in childhood cancer survivors with early echocardiographic evidence of cardiac remodeling.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | July 2015 |
Est. primary completion date | July 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 20 Years |
Eligibility |
Inclusion Criteria: 1. Enrolled in the Survivor Cohort of the PCS2 study at The Hospital for Sick Children at the time of enrollment. 2. Aged < 20 years at enrollment. 3. Weight = 25kg at enrollment 4. LVPW Z-score =-2.0 at any of the 0, 12 or 24 month PCS2 echocardiography assessments, on two consecutive echocardiograms at least 3 but no more than 15 months apart. 5. EF greater than 50% at enrollment 6. Serum potassium (to be ?5.0mMol/l) at Initiation Exclusion Criteria: 1. Known associated cardiac conditions for which angiotensin converting enzyme therapy is contraindicated (such as aortic stenosis, severe coarctation of the aorta, or hypertrophic cardiomyopathy with LV outflow tract obstruction) 2. Active malignancy detected within last 2 years (i.e. must be at least 2 years in remission) 3. Prior radiation therapy to a field that involved the heart 4. Prior symptomatic heart failure, or prior reduction in EF below 50% detected on surveillance echocardiography. 5. Use of any cardioactive medications including diuretics within the last 6 months 6. Concurrent serious or life threatening disease or extracardiac organ compromise which would limit participation in the trial or potentially have secondary effects on cardiac function, as determined by the treating physician. 7. Renal dysfunction precluding ACEi therapy, defined as serum creatinine greater than the 95th percentile for age or eGFR by the modified Schwartz formula of less than the 5th percentile prior to recruitment to the interventional trial (within 30 days of recruitment date) 8. Hypertension requiring treatment. 9. History of angioedema or ACEi hypersensitivity 10. Patients with hereditary problems of galactose intolerance, glucose-galactose malabsorption, or the Lapp lactase deficiency. 11. Upper airway obstructive lesions 12. Pregnancy 13. Breast-feeding |
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Canada | The Hospital for Sick Children | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
The Hospital for Sick Children |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of patients consenting to study | The number of eligible patients approached to join the study, the proportion consenting to the study, the proportion refusing the study (with reasons for refusal) and the proportion remaining on study at 18-months. | 18-month | No |
Secondary | LV wall thinning | Rate of change of the end-diastolic left ventricular posterior wall z-score and of the thickness to dimension ratio z-score | 18 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05562193 -
Exercise and Pain in CCS
|
N/A | |
Completed |
NCT04075734 -
Feasibility of a Self-Management + Peer Mentoring Intervention for Adolescent and Young Adult Childhood Cancer Survivors
|
N/A | |
Completed |
NCT05641636 -
Cardiovascular Disorders and Risk Factors in Childhood Cranial and Craniospinal Tumors Survivors
|
||
Recruiting |
NCT02355340 -
Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture
|
||
Recruiting |
NCT05527392 -
Virtual Health Insurance Navigation Pilot Program for Childhood Survivors (HINTII)
|
N/A | |
Completed |
NCT04947709 -
Physical Activity Post-Cancer for Adolescents and Young Adults
|
N/A | |
Completed |
NCT04520061 -
Developing a Health Insurance Navigation Program for Survivors of Childhood Cancer
|
N/A | |
Recruiting |
NCT03523377 -
Overnight Fasting After Completion of Therapy: The OnFACT Study
|
N/A | |
Recruiting |
NCT05463796 -
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
|